Suicidal obsessions as dose dependent side-effect of clozapine

Psychopharmacology Bulletin

Volumn 44, Issue 1, 2011, Pages 65-69

  Aukst Margetić, Branka ^a   Margetić, Branimir ^b   Maršanić, Vlatka Boričević ^c  

^a KBC Zagreb   (Croatia)

^b Neuropsychiatric   (Croatia)

^c Psychiatric Hospitalfor children and adolescents   (Croatia)

Author keywords

Clozapine; Quetiapine; Side effect; Suicidal obsession

Indexed keywords

CLOZAPINE; DIAZEPAM; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; ALCOHOL ABUSE; ANXIETY; ARTICLE; BIPOLAR DISORDER; CASE REPORT; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG DOSE INCREASE; DRUG WITHDRAWAL; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INSOMNIA; MALE; OBSESSION; SATISFACTION; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDAL OBSESSION;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLOZAPINE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE BEHAVIOR; SUICIDAL IDEATION;

EID: 82155201481     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hwang MY, Kim SW, Yum SY, Opler LA. Management of schizophrenia with obsessive-compulsive features. Psychiatr Clin North Am. 2009;32(4):835-851.
2. Stamouli S, Lykouras L. Quetiapine-induced obsessive-compulsive symptoms: a series of five cases. J Clin Psychopharmacol. 2006;26(4):396-400.
3. Lykouras L, Alevizos B, Michalopoulou P, Rabavilas A. Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatr. 2003;27(3):333-346.
4. Rasmussen SA, Eisen JL. The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry. 1992;53(Suppl.):4-10.
5. Özer S, Arsava M, Ertuǧrul A, Demir B. Obsessive compulsive, symptoms associated with quetiapine treatment in a schizophrenic patient: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(4):724-727.
6. Fisch RZ, Lahad A. Drug induced suicidal ideation. Isr J Psychiatry Relat Sci. 1991;28(1):41-43.
7. LaSalvia EA, Domek GJ, Gitlin DF. Fluoroquinolone-induced suicidal ideation. Gen Hosp Psychiatry. 2010;32(1):108-110.
8. Raja M, Azzoni A. Hypericum-induced mood disorder: switch from depression to mixed episodes in two patients. Int J Psychiatry Clin Pract. 2006;10(2):146-148.
9. Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord. 2010;12(1):1-9.
10. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S. International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry. 2003;60(1):82-91.
11. Khullar A, Chue P, Tibbo P. Quetiapine and obsessive-compulsive symptoms (OCS): case report and review of atypical antipsychotic-induced OCS. J Psychiatry Neurosci. 2001;26(1):55-59.
12. Anagnostou E, Esposito K, Soorya L, Chaplin W, Wasserman S, Hollander E. Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. Int J Neuropsychopharmacol. 2006;9(2):209-213.
13. Gulsun M, Gulcat Z, Aydin H. Treatment of compulsive sexual behaviour with clomipramine and valproic acid. Clin Drug Investig. 2007;27(3):219-223.
14. Poyurovsky M, Glick I, Koran LM. Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms. J Psychopharmacol. 2010;24(6):861-866.
15. Kuloglu M, Caykoylu A, Ekinci O, Yilmaz E. Lamotrigine-induced obsessional symptoms in a patient with bipolar II disorder: a case report. J Psychopharmacol. 2009;23(8):1001-1003.